Skip to content

    LENZ Therapeutics (LENZ) stock price & financials

    View LENZ earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance86.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $5.00M
    $12.50M
    $1.59M
    $1.90M
    $5.49M
    +9.7%
    Strengthening
    Operating Profit
    -$12.95M
    -$15.22M
    -$16.93M
    -$16.86M
    -$18.89M
    -45.9%
    -$38.46M
    -152.6%
    -$44.13M
    -160.7%
    -$34.17M
    -102.7%
    Weakening
    Net Profit
    -$10.21M
    -$12.65M
    -$14.62M
    -$14.91M
    -$16.70M
    -63.5%
    -$35.90M
    -183.7%
    -$41.49M
    -183.8%
    -$31.92M
    -114.0%
    Weakening
    EPS
    $-0.38
    $-0.53
    $-0.53
    $-0.59
    -55.3%
    $-1.32
    -149.1%
    $-1.02
    -92.5%
    Weakening
    Other Income
    $2.73M
    $2.57M
    $2.31M
    $2.44M
    $2.19M
    -19.9%
    $2.57M
    -0.2%
    $2.65M
    +14.5%
    $2.26M
    -7.7%
    Stable
    Interest
    Depreciation
    Profit before Tax
    -$10.21M
    -$14.41M
    -$16.70M
    -63.5%
    -$31.91M
    -121.4%
    Weakening
    MarginsOPM
    -337.1%
    -151.1%
    -2422.1%
    -2321.7%
    -622.9%
    -84.8%
    Weakening
    Tax
    0.0%
    -3.5%
    0.0%
    -0.0%
    +99.7%
    Strengthening
    ReturnsROIC
    3.4%
    4.2%
    4.9%
    5.0%
    5.6%
    +63.5%
    11.9%
    +183.7%
    13.8%
    +183.8%
    10.6%
    +114.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$19.78M$376.98M$47.73M$35.14M$20.16M$25.18M$24.21M
    Short-Term Investments
    Total Current Assets$21.10M$381.74M$275.37M$67.24M$211.92M$301.41M$233.28M
    Net PP&E$1.46M$18.08M$28.21M$372.0K$1.99M$1.92M$1.52M
    Goodwill
    Intangibles
    Total Assets$22.56M$401.99M$321.90M$70.38M$215.30M$305.88M$236.60M
    LiabilitiesTotal Current Liabilities$32.05M$12.14M$13.04M$18.51M$10.41M$21.19M$17.21M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$5.79M$1.75M$192.0K$814.0K$350.0K$122.0K
    Total Liabilities$32.36M$17.94M$25.61M$19.70M$11.22M$21.54M$17.33M
    EquityCommon Stock & APIC$1.0K$1.0K$10.0K$1.0K$1.0K$1.0K
    Retained Earnings-$70.59M-$141.35M-$242.40M-$95.25M-$145.01M-$227.14M-$300.55M
    Total Equity-$65.41M$384.05M-$24.17M-$92.71M$204.08M$284.34M$219.26M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$8.72M-$52.85M-$87.98M-$60.38M-$59.39M-$69.17M-$113.91M
    Cash from Investing-$1.54M-$5.74M-$241.86M-$29.62M-$154.48M-$75.67M-$23.23M
    Cash from Financing$30.08M$417.47M$597.0K$80.70M$199.00M$149.75M$123.62M
    SummaryCapital Expenditure-$1.54M-$5.74M-$6.59M-$30.0K-$468.0K-$827.0K-$511.0K
    Free Cash Flow-$10.27M-$58.59M-$94.57M-$60.41M-$59.86M-$70.00M-$114.42M
    FCF Margin-366.7%-532.8%

    Ratios